A new Cleveland Clinic study has identified diet-derived molecules called metabolites as main drivers of young-onset colorectal cancer risk, especially those associated with red and processed meat.
Delix plans further trials with neuroplastogen after positive Phase I data – Pharmaceutical Technology
DLX-001 is a neuroplastogen designed to promote neuroplasticity without giving rise to the deleterious attributes of first- and second-generation psychedelics. Credits: 15Studio/Shutterstock.com Delix Therapeutics is
July 15, 2024